$AUPH
Aurinia Pharmaceuticals Inc
PRICE
$10.38 β²0.679%
Extented Hours
VOLUME
8,338,512
DAY RANGE
9.22 - 10.66
52 WEEK
4.07 - 13.42
Key Metrics
Market Cap
1.47 B
Beta
1.25
Avg. Volume
3.31 M
Shares Outstanding
142.58 M
Yield
0%
Public Float
0
Next Earnings Date
2023-05-09
Next Dividend Date
Company Information
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Companyβs head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.
CEO: Peter Greenleaf
Website: www.auriniapharma.com
HQ: 1203-4464 Markham St Victoria, V8Z 7X8 British Columbia
Related News